Victor Forge
Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterised by progressive muscle degeneration and weakness. It is caused by a mutation in the gene that produces a protein called dystrophin, which is critical for keeping muscle cells intact. DMD was first described by French neurologist Guillaume Benjamin Amand Duchenne in the 1860s, and it is now known to be the most common hereditary neuromuscular disease. The disease causes muscle weakness that quickly worsens over time, with symptoms usually appearing between the ages of 2 and 4 years, but sometimes as late as 6 years. DMD affects the skeletal and heart muscles, and can lead to life-threatening complications such as cardiomyopathy, which causes deterioration of the heart muscle and can result in heart failure.
| Characteristics | Values |
|---|---|
| Prevalence | Approximately 6 per 100,000 individuals in Europe and North America |
| Type of Disease | Genetic disorder |
| Gene Involved | DMD gene on the X chromosome |
| Protein Involved | Dystrophin |
| Inheritance Pattern | X-linked recessive |
| Age of Onset | Early childhood, usually between ages 2 and 3 |
| Symptoms | Muscle degeneration, weakness, and atrophy, especially in the pelvic area, shoulders, and limbs; enlarged calf muscles; learning problems; cardiac and orthopedic complications |
| Progression | Progressive muscle weakness and atrophy spread to the trunk, forearms, and additional body muscles; most affected individuals require a wheelchair by the teenage years |
| Treatment | Palliative care, glucocorticoids, and physiotherapy; FDA-approved drugs: deflazacort (Emflaza), Vyondys 53, and Viltepso |
| Prognosis | Serious life-threatening complications, including cardiomyopathy and respiratory difficulties, may develop; affected patients usually die in their twenties |
Explore related products
What You'll Learn
- DMD is a genetic disorder characterised by progressive muscle degeneration and weakness
- DMD is caused by mutations in the dystrophin gene, which is essential for maintaining muscle fibres
- The condition mainly affects boys, but girls who are carriers can sometimes show mild symptoms
- Symptoms of DMD usually appear between the ages of 2 and 6 years, with rapid progression
- There is currently no cure for DMD, and treatment options are palliative
DMD is a genetic disorder characterised by progressive muscle degeneration and weakness
Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterised by progressive muscle degeneration and weakness. DMD is caused by a mutation in the gene that gives instructions for a protein called dystrophin. Dystrophin is essential for maintaining the integrity of muscle fibres, and its absence leads to fragile and easily damaged muscle cells. The condition causes skeletal and
DMD is the most common and one of the most severe forms of inherited muscular dystrophies, predominantly affecting young boys. It is caused by mutations or deletions in any of the 79 exons encoding the large dystrophin protein. While girls can be carriers and experience mild symptoms, the disease is much rarer in females, occurring in approximately one in 50 million live female births. Symptoms of DMD usually appear between the ages of 2 and 6 years, though they can begin as early as infancy or be noticed later in childhood.
The onset of muscle weakness typically begins around age four and progresses rapidly. A classic sign of DMD is trouble getting up from a lying or sitting position. As the disease advances, individuals may experience additional complications, such as reduced bone density, learning disabilities, and intellectual impairment. By the late teens, DMD may lead to life-threatening conditions, including weakness and deterioration of the heart muscle (cardiomyopathy), which can result in heart failure and respiratory muscle weakness.
While there is currently no cure or treatment to halt the progression of DMD, various medications are available to manage symptoms and slow down muscle degeneration. These include gene therapy, antisense drugs, glucocorticoids, calcium channel blockers, anticonvulsants, and histone deacetylase inhibitors. With comprehensive care, some individuals with DMD may live into their 30s or 40s.
Reversing Bladder Muscle Weakness: Is It Possible?
You may want to see also
Explore related products
DMD is caused by mutations in the dystrophin gene, which is essential for maintaining muscle fibres
Duchenne Muscular Dystrophy (DMD) is a severe type of muscular dystrophy that causes progressive muscle degeneration and weakness. DMD is caused by mutations in the dystrophin gene, which is essential for maintaining muscle fibres. This gene is responsible for producing a protein called dystrophin, which plays a critical role in keeping muscle cells intact. When this gene is flawed or mutated, it leads to a reduced production of dystrophin, causing muscle cells to become fragile and easily damaged.
The dystrophin protein is a crucial component of the dystrophin-glycoprotein complex (DGC), which functions as a structural unit of muscle. Mutations in the dystrophin gene result in a limited synthesis of this protein, leading to muscle fibre disarray, death, and replacement with connective tissue or fat. This process of muscle deterioration progresses rapidly, causing severe muscle weakness and loss of muscle mass.
Symptoms of DMD typically appear between the ages of 2 and 6 years, with muscle weakness being the most prominent feature. Initially, muscle loss occurs in the thighs and pelvis, later extending to the arms, leading to difficulties in standing up. As the disease progresses, it can cause additional complications, such as weakness and deterioration of the heart muscle (cardiomyopathy), which can become life-threatening.
DMD predominantly affects boys, with a much lower occurrence in females. Girls who are carriers of the mutated gene may exhibit mild symptoms, while affected boys experience rapid muscle degeneration and severe weakness. Currently, there is no cure for DMD, and available treatment options focus on palliative care to manage symptoms and slow the progression of the disease.
In summary, DMD is a debilitating genetic disorder caused by mutations in the dystrophin gene, resulting in a deficiency of the dystrophin protein. This protein is vital for maintaining muscle fibre integrity, and its absence leads to progressive muscle deterioration characteristic of DMD. While palliative treatments can help manage symptoms, further research is ongoing to develop more effective interventions for this devastating disease.
Measuring Muscle Thickness: Techniques and Tools for Accuracy
You may want to see also
Explore related products
The condition mainly affects boys, but girls who are carriers can sometimes show mild symptoms
Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterised by progressive muscle degeneration and weakness. It is caused by a mutation in the gene that is responsible for producing a protein called dystrophin, which is essential for maintaining the integrity of muscle fibres. This condition predominantly affects boys, with symptoms usually appearing between the ages of 2 and 4 years old, though they can begin as early as infancy or as late as 6 years old.
Girls can also be carriers of the mutated gene and, in rare cases, may exhibit mild symptoms. Duchenne muscular dystrophy is considerably rarer in females, occurring in approximately one in 50,000,000 live female births. While carrier females typically show no evidence of muscular weakness, there have been cases of symptomatic female carriers. These girls may experience milder symptoms, such as learning disabilities and mild intellectual impairment, which are also observed in some affected boys.
The symptoms of DMD include skeletal and heart muscle weakness that worsens over time, leading to difficulties in standing up and walking. The muscle loss typically begins in the thighs and pelvis, eventually extending to the arms. This condition can also cause reduced bone density, increasing the risk of fractures in certain bones like the hips and spine.
As the disease progresses, it can lead to potentially life-threatening complications, such as cardiomyopathy, which affects the heart's ability to pump blood, resulting in irregular heartbeats and heart failure. Respiratory muscle weakness is another serious complication that can lead to death. While there is currently no cure or treatment to halt the progression of DMD, palliative care and certain medications can help manage symptoms and slow down skeletal and cardiac muscle degeneration.
DMD was first described by French neurologist Guillaume Benjamin Amand Duchenne in the 1860s. However, it wasn't until the 1980s that researchers identified the specific gene mutation on the X chromosome that causes this condition.
Relieving Muscle Tension: Simple and Effective Strategies
You may want to see also
Explore related products
Symptoms of DMD usually appear between the ages of 2 and 6 years, with rapid progression
Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterised by progressive muscle degeneration and weakness. It is caused by a mutation in the gene that gives instructions for a protein called dystrophin, which is critical for keeping muscle cells intact. Symptoms of DMD usually appear between the ages of 2 and 6 years, with rapid progression.
The first signs of DMD often include muscle weakness and atrophy, beginning in the legs and pelvis and spreading to the arms, neck and other areas. This can lead to trouble walking and a late start to walking in toddlers. Parents may notice enlarged calf muscles, a condition known as pseudohypertrophy, which can also occur in the thigh muscles. A child with DMD may seem clumsy and fall often.
As DMD progresses, muscle weakness and deterioration worsen, leading to increased dependence on mobility aids such as braces, canes and, eventually, a wheelchair. By the late teens, the condition may be characterised by life-threatening complications, including weakness and deterioration of the heart muscle (cardiomyopathy). Cardiomyopathy can lead to heart failure, irregular heartbeats and impairment in the heart's ability to pump blood.
In addition to physical symptoms, children with DMD may also experience mild to moderate degrees of non-progressive intellectual impairment and learning disabilities. Serial monitoring of breathing capacity should begin at the age of 5 or 6, as respiratory issues can become a serious concern. Weakened respiratory muscles can lead to an increased risk of respiratory infections, with even a simple cold quickly progressing to pneumonia.
Muscle Growth and Flexibility: Friends or Foes?
You may want to see also
Explore related products
There is currently no cure for DMD, and treatment options are palliative
Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterised by progressive muscle degeneration and weakness. It is caused by a mutation in the gene that produces dystrophin, a protein that helps keep muscle cells intact. As a result, people with DMD experience muscle weakness and deterioration, which can lead to difficulty in standing up, moving, and performing other physical activities.
While there is currently no cure for DMD, various treatment options are available to help manage the condition and improve patients' quality of life. Treatment for DMD typically involves a multidisciplinary approach, including medications, physical therapy, and assistive devices.
Medications such as corticosteroids, including prednisone and deflazacort, are often prescribed to slow the progression of DMD and improve muscle strength. Other medications like calcium channel blockers and anticonvulsants may also be used to address specific symptoms and slow skeletal and cardiac muscle degeneration. Additionally, gene therapy and antisense drugs are being investigated as potential treatments to address the root cause of DMD.
Physical therapy plays a crucial role in helping individuals with DMD maintain muscle strength, flexibility, and mobility. Physiotherapists can design tailored care plans and exercise programs to help patients improve their strength and range of motion, which can, in turn, enhance their overall functionality and independence.
Assistive devices such as wheelchairs, transfer boards, mechanical lifts, shower chairs, and electronic beds can also be utilised to improve mobility and independence. These devices can make daily tasks easier and help individuals with DMD perform activities of daily living with greater ease.
While these treatments cannot cure DMD, they aim to provide palliative care by relieving symptoms, improving quality of life, and prolonging life. Additionally, ongoing research and clinical trials are actively investigating new treatment approaches, offering hope for future advancements in managing and potentially curing DMD.
Lift Your Chest: Simple Muscle-Building Workouts and Techniques
You may want to see also
Frequently asked questions
Duchenne Muscular Dystrophy (DMD) is a severe type of muscular dystrophy predominantly affecting boys. It is a genetic disorder characterised by progressive muscle degeneration and weakness due to the alterations of a protein called dystrophin that helps keep muscle cells intact.
The onset of muscle weakness typically begins around the age of four, with rapid progression. Initially, muscle loss occurs in the thighs and pelvis, extending to the arms, which can lead to difficulties in standing up. Other symptoms include reduced bone density, mild to moderate degrees of non-progressive intellectual impairment and learning disabilities.
DMD is caused by a mutation in the gene that gives instructions for the dystrophin protein. This protein is essential for maintaining the muscle fibres' cell membrane integrity.
